C
olicins are proteinaceous antimicrobial agents produced by Escherichia coli strains and other related species and genera of the family Enterobacteriaceae. All of them share a similar molecular structure comprising three domains for colicin translocation, receptor binding, and lethal effect (11) . To date, more than 20 various colicin types have been described on the molecular level (11, 52, 57, 64, 68) . Although most of the colicin types were identified among E. coli strains, bacteriocins with a molecular structure similar to that of colicins have been found among strains of the genera Citrobacter, Escherichia, Klebsiella, Pseudomonas, Salmonella, Shigella, Yersinia, and others (11, 32, 43, 61, 68) .
Colicins are directed against closely related strains of the producer's species, and therefore, colicinogenic strains are believed to have a selective advantage compared to related noncolicinogenic strains. In general, colicins are directed against both commensal and pathogenic E. coli strains, except for colicin Js, which is active against enteroinvasive E. coli, just as Shigella strains (28, 65) . Although the precise general role of colicins in the human gut is unknown, there is increasing evidence for bacteriocin-enhanced E. coli colonization of the gastrointestinal tract (21) , for the role of colicins in bacterial virulence (e.g., colicin E1 [62] ), and for colicin's role in the probiotic phenotype of E. coli strains (14, 63) .
Three of 17 species of the genus Yersinia (Enterobacteriaceae) are known as important human pathogens (Y. pestis, Y. enterocolitica, and Y. pseudotuberculosis), while the other species comprise nonpathogenic strains or opportunistic pathogens (30, 42, 46, 47, 70, 71, 73) . Production of bacteriocins has already been described in two pathogenic (Y. pestis and Y. pseudotuberculosis) and in two nonpathogenic (Y. intermedia and Y. kristensenii) Yersinia species (4, 5, 8, 60, 77) . However, only pesticin I has been characterized on the molecular level as being active against strains of Y. pestis, Y. pseudotuberculosis, and E. coli C6 (⌽) (4, 8, 29, 54, 55, 80) .
In this communication, we describe a novel colicin type (F Y ) isolated from a strain of Yersinia frederiksenii, its complete plasmid sequence (pYF27601), the corresponding receptor, translocation routes to susceptible strains, and activity spectra against strains of related species. (strains Y7587, Y7782, Y7886, Y8008, Y8472, Y8703, Y8773,  Y8886, Y9081, Y9102, Y9464, Y9949, Y9953 , and Y10141) were isolated from patients at the Faculty Hospital Brno-Bohunice in Brno, Czech Republic. The standard colicin indicator strains used were E. coli K-12 Row, C6 (⌽), B1, and P400 and Shigella sonnei strain 17 (62, 67) . A list of the other strains, plasmids, and primers used in this work is shown in Table 1 . Culture media. TY medium consisting of 8 g/liter tryptone (Hi-Media, Mumbai, India), 5 g/liter yeast extract (Hi-Media), and 5 g/liter sodium chloride in water was used throughout the study. TY agar consisted of a base layer (1.5%, wt/vol) and a top layer (0.75%, wt/vol). For protease sensitivity testing, 0.005% (wt/vol) trypsin (Sigma, St. Louis, MO) was added to 1.5% agar. Chloramphenicol (0.025 g/liter; Sigma), kanamycin (0.050 g/liter; Sigma), or ampicillin (0.100 g/liter; Sigma) was added for selection or maintenance of plasmids. For induction of colicin synthesis, mitomycin C (0.0005 g/liter; Sigma) or L-(ϩ)-arabinose (0.2 g/liter; Sigma) was added to the culture medium 4 h prior to bacterial harvesting.
MATERIALS AND METHODS
Detection of colicin production. Detection of colicin production was performed as described previously (69) . Briefly, the agar plates were inoculated by a stab of the producer being tested and incubated at 37°C for 48 h. The macrocolonies were killed using chloroform vapors (30-min exposure), and each plate was then overlaid with a thin layer of top agar containing 10 8 cells of an indicator strain. The plates were then incubated at 37°C overnight, and zones of growth inhibition were read.
Preparation of crude colicin extracts and colicin activity assays. Strains Y. frederiksenii Y27601 and PK11.3 (Table 1) were used for colicin F Y production. A 20-fold-diluted overnight TY culture of a colicinogenic strain, induced by mitomycin C, was incubated for an additional 4 h and centrifuged for 15 min at 4,000 ϫ g; the sediment was resuspended in 5 ml of distilled water, washed twice in distilled water, and sonicated. The resulting bacterial lysate was centrifuged for 15 min at 4,000 ϫ g, and the supernatant was used as a crude colicin preparation. Antibacterial colicin activity was tested by spotting of 10-fold serial dilutions of crude colicins on agar plates with inoculated indicator strains. The indicator bacteria (10 8 cells) were added to the 3-ml top layer of TY agar and poured on a TY plate. The reciprocal of the highest dilution of the colicin-containing cell lysate or purified colicin solution causing growth inhibition of susceptible bacteria was considered the colicin titer (in arbitrary units). The data represent the average results of three independent experiments.
Isolation of plasmid YF27601, in vitro transposition, and DNA sequencing and annotation. Plasmid DNA was isolated using a QIAprep spin miniprep kit and Qiagen plasmid midikit (Qiagen, Hilden, Germany). The manufacturer's recommendations were followed. Plasmid mutagenesis was performed using an in vitro Tn7 transposition system (GPS-1 genome priming system, New England BioLabs, Beverly, MA) according to the manufacturer's recommendations. The DNA in the vicinity of the inserted Tn7 transposon was sequenced using primers Tn7RN and Tn7LS. Plasmid DNA of recombinant strains PK11.1 and PK11.2 was used to construct small insert libraries using the pUC18 vector. Ninety-six colonies were dideoxy terminator sequenced using pUC18 primers for each pPK11.1 and pPK11.2 template. DNA sequencing was performed using a Taq DyeDeoxy terminator cycle sequencing kit (Applied Biosystems, Foster City, CA). Gene predictions and annotations were performed using Glimmer software (version 3.02; http://www.cbcb .umd.edu/software/glimmer/) (16) and GeneMark software (http://exon .biology.gatech.edu/) (41) . The Lasergene program package (DNAStar, Madison, WI) was used for manipulation and assembly of the sequence data.
Chromosome mutagenesis and identification of receptor mutants. The chromosomal in vivo mutagenesis protocol (58) was used for transposon inactivation of the colicin F Y receptor gene of susceptible Y. kristensenii Y276. Plasmid NKBOR was isolated from the E. coli DH5␣ pir strain and subsequently electroporated to Y. kristensenii Y276. Recombinant colonies were placed on 1.5% TY agar containing kanamycin (0.050 g/liter) and colicin F Y (200 l of crude sterile lysate, 100 arbitrary units). The resulting colonies were picked and cultivated in liquid TY medium overnight, and then their susceptibility to colicin F Y was verified using the colicin activity assays described above. The standard cetyltrimethylammonium bromide method was used to isolate the chromosomal DNA from colicin F Y -resistant mutants. Phenol-chloroform extraction was used to purify the chromosomal DNA (59) . Chromosomal DNA (1 to 5 mg) was digested using 5 U of EcoRI (New England BioLabs) (or alternatively the SpeI or EciI enzyme) at 37°C for 3 h, and the restriction digestion Table 1) . The PCR product (1.7 kb) was cloned using a TOPO TA cloning kit (Invitrogen, Carlsbad, CA), resulting in pDS1006. The cfyA and cfyI genes were then recloned into pBAD-A vector (Invitrogen), where cfyA was fused at its 5= end to DNA encoding the His tag. The resulting pDS1068 was transformed into the expression strain E. coli TOP10F=. Colicin F Y was prepurified from overnight culture (5 liters) of E. coli TOP10F=(pDS1068) using Ni-nitrilotriacetic acid agarose (Qiagen). Prepurified colicin F Y was further separated from other proteins using the AKTA fast protein liquid chromatography system (GE Healthcare, Fairfield, CT) and MonoQ 5/50 GL columns (GE Healthcare). Purified colicin F Y samples were mixed with 2ϫ Laemmli sample buffer and boiled for 10 min. Samples were separated on SDS-PAGE gels (12%) and electrotransferred (100 V/1 h) onto Immobilon-P transfer membrane (Millipore, Billerica). The His-tagged colicin F Y was detected using a Penta-His horseradish peroxidase conjugate kit (Qiagen) and a chemiluminescent reagent, Lumi-Light Western blotting substrate (Roche, Branford, CT). The His tag was removed from the colicin F Y (500 ng) by treatment with 5 U of enterokinase (New England BioLabs) at 25°C for 90 min.
Cloning of colicin F Y receptor and complementation of resistant bacteria. The yiuR gene encoding the receptor of colicin F Y was amplified from the chromosomal DNA of susceptible strain Y. kristensenii Y276 with YE1461SD-F and YE1461-R primers and Pfu polymerase (Fermentas, Glen Burnie, MD). The resulting PCR product (1,974 bp) was cloned into the pCR 2.1-TOPO TA cloning vector, and the resulting plasmid (pDS1082) was verified by sequencing and transformed into resistant Y. kristensenii Y104, E. coli TOP10F=, and Y. pseudotuberculosis Y207240. The whole yiu locus (yiuBCR genes) was cloned similarly using primers YE1459SD-F and YE1461-R, resulting in pDS1088. The tonB gene from Y. kristensenii Y276 was cloned using an In-Fusion advantage PCR cloning kit (Clontech, Mountain View, CA) using primers infusionYE2222F and infusionYE2222R. The resulting plasmid (pDS1091) was verified by sequencing and transformed into resistant E. coli TOP10F=. The colicin F Y activity assays were used to determine the susceptibility of the transformed bacteria to colicin F Y .
Construction of phylogenetic trees. The software PAUP* 4b10 (82) and its free graphical user interface PaupUp (version 1.0.3.1. beta; http: //www.agro-montpellier.fr/sppe/Recherche/JFM/PaupUp/) were used for construction of phylogenetic trees using the nucleotide sequences of the 3= ends (ϳ500 bp) of colicin activity genes. The DNA sequences used for tree constructions were aligned using ClustalX software, which is available on-line (version 2.0; http://www.clustal.org/) (40) , and ModelTest (version 3.7; http://darwin.uvigo.es/software/modeltest.html) (53) was used to identify the best model of nucleotide substitutions. Phylogenetic trees were constructed by the maximum-likelihood method from the best model identified by ModelTest. TreeView software (version 1.6.6; http://taxonomy.zoology.gla.ac.uk/rod/treeview.html) (48) was used for graphical presentations of the corresponding trees.
Prediction of protein structures. The positions of external loops in the YiuR protein were predicted by the hidden Markov model method (http://biophysics.biol.uoa.gr/PRED-TMBB/) (2, 3) .
Nucleotide sequence accession numbers. The nucleotide sequence of plasmid YF27601 was deposited in the GenBank database under accession number JF937655. The yiuR and tonB gene sequences of Y. kristensenii strain Y276 were deposited under accession numbers JF937653 and JF937654, respectively. Table 2 ). None of the standard colicin indicator strains K-12 Row, C6 (⌽), B1, P400, and S. sonnei 17 (62) were susceptible to this colicin.
RESULTS

Inhibitory
Isolation and sequencing of plasmid YF27601. In order to identify the plasmid encoding colicin F Y , the total plasmid DNA of the strain Y. frederiksenii Y27601 was subjected to in vitro transposon mutagenesis with Tn7. The recombinant DNA was used to transform E. coli DH10B. Selection for chloramphenicol resistance resulted in 12 recombinant colonies (named PK11.1 to PK11.12). The PK11.8 strain was excluded because of ambiguous sequencing results. Nine of the remaining 11 colonies were able to inhibit Y. kristensenii Y276 indicator bacteria. Plasmid DNA preparations of strains PK11.1 and PK11.2 were used to construct a small insert library. The resulting clones were used for sequencing of the plasmid DNA (96 clones of each plasmid). More than 16ϫ average sequencing coverage was obtained for both pPK11.1 and pPK11.2. In addition, specific oligonucleotides were used to finish the complete plasmid sequence. The complete plasmid DNA (excluding the transposon DNA sequence) comprised 5,574 bp, and the plasmid was named pYF27601 (Fig. 1) .
Sequence analysis of pYF27601. The complete sequence of pYF27601 was numbered from the unique BamHI restriction target site starting with its first recognized nucleotide (GGATCC). The pYF27601 sequence comprised 8 predicted open reading frames (ORFs) encoding polypeptides longer than 50 amino acid residues ( Table 3 ). The average GϩC content of this plasmid sequence was 50.0%; however, the colicin F Y -encoding gene and colicin F Y immunity gene showed lower GϩC contents (42.1% and 30.7%, respectively). Three ORF types with predicted functions were found in pYF27601, including ORFs encoding plasmid mobilization (mobA and mobC) and colicin production (cfyA and cfyI) and ORFs homologous to ORFs present in insertion sequence elements (isnA and isnB). A 964-nucleotide (nt) sequence of pYF27601 (nt 5497 to 886) was found to be very similar (77% nucleotide sequence identity) to the origin of replication of plasmid AlvA of H. alvei (81) . In this 964-nt region of pYF27601, the RNAI and RNAII promoter sequences (Ϫ35 and Ϫ10 regions) were identified based on similarity to corresponding sequences of pAlvA and pColE1. Analysis of the colicin F Y activity and immunity genes. The colicin F Y -encoding gene was named cfyA, and the corresponding protein CfyA contained 438 amino acid residues with a calculated molecular mass of 49.6 kDa. Colicin F Y synthesis in PK11.1 and PK11.2 was inactivated by Tn7 insertion into the cfyA gene with insertion target sequences between coordinates 3047 to 3051 and 3613 to 3617, respectively. Upstream from cfyA, a ribosome binding site (AGGGA, coordinates on pYF27601, 2897 to 2901), puta- tive promoter Ϫ10 and Ϫ35 regions (TTGACA, 2817 to 2822, and TAGTAT, 2840 to 2845), and a single LexA binding site (CTGTA TGTATATACAG, 2853 to 2868) were found. The cfyI gene encoding the colicin F Y immunity protein was oriented opposite to cfyA and a near-consensus promoter (Ϫ10 and Ϫ35 sequences) was found upstream from the cfyI gene (TTGACA, 4660 to 4665, and TAAAAA, 4636 to 4641). In addition, 13-bp inverted repeats were found in the 3= region of the cfyI gene and in the intergenic region of cfyA-cfyI (4229 to 4241 and 4252 to 4264). These repeats represent potential transcription termination sites. The deduced amino acid sequence of colicin F Y revealed relatively low homology in the 260-amino-acid-long N-terminal and central sequence, including 31% amino acid identity with an uncharacterized colicin from Arsenophonus nasoniae (CBA74339) and 28% identity with an S-type pyocin domain-containing protein of Serratia proteamaculans 568 (YP_001476768), which suggested novel receptor specificity of colicin F Y . At the N terminus of colicin F Y , a near-consensus TonB box was found between amino acid residues 42 and 48 (DTMTVTG), indicating a possible interaction between colicin F Y and the TonB protein. The last 178 amino acid residues, the C-terminal domain of colicin F Y , showed 69% identity with the C-terminal domain of colicin Ib, encoded in the genome of Yersinia ruckeri ATCC 29473 (ZP_04617830), and 57% identity with the C-terminal domain of colicin Ib of Escherichia fergusonii EF6 (AF_453413.1) The pore-forming activity of colicin F Y was verified by lipid bilayer experiments (R. Fišer, unpublished data). The immunity protein of colicin F Y showed 39% identity in 105 aligned residues to the immunity protein from A. nasoniae (CBA74337) and 37% identity in 111 aligned residues to the immunity protein of colicin Ib from S. sonnei P9 (NP_052460).
Purification of colicin F Y . The E. coli TOP10F= strain, containing pDS1068 encoding colicin F Y with an N-terminal His tag (HTcolicin F Y ), was used to produce larger amounts of HT-colicin F Y for purification. HT-colicin F Y was purified (0.1 mg/ml; i.e., approximately 10 12 molecules per l) with a corresponding activity of 100 arbitrary units per l. Removal of the His tag from purified HT-colicin F Y resulted in 10-fold increased activity of colicin F Y compared to that of HT-colicin F Y . This fact indicated the importance of an intact colicin N terminus in its bactericidal activity (Fig. 2) .
Identification and characterization of colicin F Y receptor. Transposon mutagenesis with suicide plasmid NKBOR (58) and selection for resistance to kanamycin and to colicin F Y resulted in 66 colonies of Y. kristensenii Y276. Fifty colonies were further analyzed, and 42 of them showed complete resistance to colicin F Y (to 100 arbitrary units of colicin F Y ), whereas 8 colonies showed decreases in susceptibility to colicin F Y of 1 order of magnitude or less (results of transposon mutagenesis are shown in Fig. 3 ). Twenty-three (out of 50) colonies were sequenced, and 19 of them revealed an insertion in the yiuR gene (ykris001_4440; GenBank accession no. ACCA01000005.1). Four clones contained an insertion in one of the two genes upstream from yiuR (i.e., the yiuB and yiuC genes). All four insertions in the yiuB or yiuC gene showed decreases in susceptibility to colicin F Y of 1 order of magnitude and no complete resistance, as detected in yiuR insertions.
To verify the function of the yiuR gene in colicin F Y susceptibility, a colicin F Y -resistant strain Y. kristensenii Y104 was transformed with pDS1082 harboring the yiuR gene. Susceptibility to colicin F Y was fully restored in this Y. kristensenii Y104 yiuR ϩ strain (Table 4) . Susceptibility was also restored in Y. pseudotuberculosis strain 207240. In contrast, introduction of the yiuR gene into the E. coli TOP10F= strain did not result in acquisition of susceptibility to colicin F Y . However, introduction of the yiuR gene together with tonB from Y. kristensenii (harbored in pDS1091) into E. coli resulted in the recombinant strain becoming fully susceptible to colicin F Y . (10 12 in this purified sample) and the number of lethal colicin units in one arbitrary unit for colicins E1 to E9 (arbitrary unit ϭ 2 ϫ 10 8 lethal units [66] ), one lethal unit (i.e., the lowest number of colicin molecules able to kill one susceptible bacterium) of colicin F Y corresponds to approximately 5 molecules.
DISCUSSION
Although the majority of colicin types have been identified in E. coli strains, a number of colicins have been identified for the first time in different enterobacterial strains, including Citrobacter freundii CA31 (colicin A; 45), Serratia marcescens JF246 (colicin L; 18), S. sonnei P9 (colicins E2, Ia, and Ib; 12, 38), S. sonnei 7 (colicin Js; 1), and S. boydii M592 (colicin U; 27). In addition, several bacteriocins were named differently although the principal features of these proteins are similar to those of colicins, including bacteriocin 28b of S. marcescens N28b (79), pesticin I of Yersinia pestis A1122 (4, 29) , cloacin DF13 of Enterobacter cloacae DF13 (72), and S-type pyocins of Pseudomonas aeruginosa (reviewed in reference 43). All of the above-mentioned bacteriocins are proteasesensitive proteins with a modular structure containing receptor, translocation, and killing domains similar to those of colicin proteins. Because of the modular proteinaceous structure, the novel, proteasesensitive (data not shown) bacteriocin of Y. frederiksenii was named colicin F Y . The letter F remained unused (the originally identified colicin F was reclassified as colicin E2 [19] in the list of colicin types, and the index Y stands for Yersinia. Strains of Y. frederiksenii (both colicin F Y susceptible and producer strains) were found among nonsymptomatic fecal carriers, and these strains are generally considered nonpathogenic or moderately pathogenic (10, 73) . Like other colicin producers, strains of Y. frederiksenii belong to bacteria living in animal and human guts, and the producer strains may have a selective ecological advantage in microbiocenoses typical for this environment (24, 34) .
Colicin F Y showed an inhibitory effect against strains of several Yersinia species (five out of eight tested). Interestingly, the highest number of susceptible strains was found in strains of Y. enterocolitica. These strains cause most of the human diarrheal yersinia infections (especially in children), representing 1 to 9% of all cases of diarrhea (44, 84) . Colicin F Y was also active against other nonpathogenic strains of "enterocolitica-like group" (73), including Y. frederiksenii, Y. intermedia, Y. kristensenii, and Y. aldovae. This is the first colicin characterized in detail that is active mainly against the pathogenic species Y. enterocolitica and related "enterocolitica-like" species. On the other hand, not a single strain of Y. pseudotuberculosis was found to be susceptible to colicin F Y , despite the fact that both Y. enterocolitica and Y. pseudotuberculosis are primarily gut pathogens; however, the yiuR genes of the two species differ significantly, and our results revealed that transfer of yiuR from Y. kristensenii to strains of Y. pseudotuberculosis resulted in acquired susceptibility to colicin F Y . Therefore, amino acid residues different in both YiuR proteins specify recognition of colicin F Y by this receptor. Residues interacting with colicin F Y are likely to be found on externally exposed loops 1 to 11 of the YiuR receptor (Table 5 ). For comparison, most of the sites of interaction between the receptor domain of colicin Ia and the Cir receptor (homologous to YiuR) were identified in Cir loops L7 and L8 (9) . Interestingly, these loops in the YiuR receptor are the longest and most divergent between Y. kristensenii and Y. pseudotuberculosis (Table 5 ) and may therefore specify interaction with colicin F Y .
As shown by multilocus sequencing, Y. pestis and Y. pseudotuberculosis are very closely related and represent two lineages of the same species (39) . Y. pestis strains are known to possess a yiuR gene (35) that is very closely related to the yiuR gene of Y. pseudotuberculosis, and therefore, strains of Y. pestis are unlikely to be susceptible to colicin F Y .
Colicin F Y was found to be encoded by a low-molecular-weight Except of colicin F Y activity and immunity genes, genes for plasmid maintenance (plasmid mobilization) and the IS1 sequence (encoding transposase) were found on pYF27601. Like other colicin plasmids, including ColE1, ColJs, ColK, Col-Let, ColE2, etc., the primary role of this plasmid is probably the synthesis of colicin F Y itself. Based on sequence homology, pYF27601 replicates using the theta mechanism, which is similar to AlvA-and other ColE1-type plasmids (31, 49, 57, 74, 81) . However, due to sequence diversity, only the promoter regions of RNAI and RNAII were predicted (Table 3) . Although the precise transcription starts of RNAI and RNAII genes are not known, the complementary regions of RNAI and RNAII molecules specified plasmid incompatibility. The overlapping RNAI and RNAII sequences (incompatibility region) differ substantially (ϳ70% identity) between pYF27601 and pColE1 (26, 76) . This prediction was verified experimentally; pYF27601 was stably maintained in TOP10F= bacteria with pCR 2.1-TOPO, a vector containing pColE1-derived replication (data not shown). Therefore, pYF27601 is likely to be compatible with ColE1-like plasmids. Sequence analysis of the colicin F Y -encoding region revealed a single LexA binding site (SOS box), suggesting a lower level of SOS induction of colicin F Y synthesis. In addition to colicin F Y , other colicin gene clusters (e.g., those encoding colicins Ia, Ib, cloacin DF13, and some klebicins) have been shown to possess a single LexA binding site. Colicin synthesis under a single LexA repressor is increased under noninducing conditions with a lower response on SOS induction (22) . In fact, experimental induction of the SOS response did not lead to a detectable increase in colicin F Y synthesis (data not shown). The cfyI gene encoding the colicin F Y immunity protein was found to be oriented opposite to the cfyA gene, a situation common in all colicin types that does not require proportional synthesis of colicins and the corresponding immunity proteins, including pore-forming colicins, peptidoglycan-degrading pesticin I and colicin M (inhibitor of murein synthesis). In contrast to other colicin immunity genes of pore-forming colicins, the nearly consensus promoter (Ϫ10 and Ϫ35 sequences) upstream from cfyI suggests relatively strong transcription of the cfyI gene.
Colicin F Y and its immunity protein showed the highest similarity to colicin and immunity protein from A. nasoniae and to colicin Ib and colicin Ib immunity protein Ib, respectively. A. nasoniae is an entomopathogenic bacterium (Enterobacteriaceae) related to bacteria of the genera Photorhabdus, Proteus, Serratia, and Yersinia (15) . However, the colicin-encoding region in the genome of A. nasoniae was predicted without further characterization (83) . The most closely related characterized colicin type was pore-forming colicin Ib (Fig. 4) , although only a cytotoxic domain had a similar sequence. In fact, cfyI-positive E. coli strains were partially immune to colicin Ib (data not shown), suggesting common ancestry for colicin F Y -and Ib-encoding regions. QDRNTTAGRSVALNG **K*S*P**TL**** L4 (290-314) GNSTSYVQRDETRNPSREMKSVDNI ******I**********Q******* L5 (337-359) EELYDEGNQLASAKDLTKLTRGS *****K****P**S**K****W* L6 (383-391) DQDENYGTH ***Q***** L7 (417-450) RSPDLRQATDNWGQITGGK-GDPAIIVGNSSLKPE **********D***LS**GKG*L**L*L***N**** L8 (476-518) TDFKDKITEVRRCTDTTGKASGQCMINGNSYKFISDRTNVDKA ***********N*DI**-NTT***VF**IN*******I***** L9 (544-563) TQSEQKSGQFSGKPLNQMPK ********A*A*Q******* L10 (587-614) RGKTSEYLNRTSIGTTTPSYTFVDLGAN ***A********M*SR************ L11 (640-648) NDKVLDGRR ********* Since none of the standard colicin E. coli indicators were susceptible to colicin F Y , the Yersinia-specific receptor and/or translocation system required by colicin F Y was expected. Transposon mutagenesis revealed yiuR as the gene encoding the putative colicin F Y receptor. Although YiuABC proteins were shown to be involved in the iron acquisition system in Y. pestis, YiuR was not required for iron uptake (35) ; as a result, the function of the predicted outer membrane receptor YiuR protein remains unknown. YiuR displayed 37% identity with the Cir protein of E. coli involved in iron acquisition and in colicin and microcin uptake (9, 11, 33, 37, 50) . Interestingly, introduction of the yiuR gene into E. coli strain TOP10F= did not restore susceptibility to colicin F Y . However, introduction of both the yiuR and tonB genes from Y. kristensenii restored the susceptibility of E. coli strain TOP10F= to colicin F Y . The fact that the tonB gene of Y. kristensenii Y276 was not found by screening of colicin F Y -unsusceptible insertion mutants probably reflects a decreased viability of Y. kristensenii tonB mutants similar to that of Salmonella enterica serovar Typhi (23) and Escherichia coli strain C6 (⌽) tonB mutants (17) . The tonB gene of Y. kristensenii (tonB YK ) and the tonB gene from E. coli DH10B are identical at only 46% of their amino acid residues. Lack of cross-complementation in E. coli was also described for TonB of Y. enterocolitica (TonB YE ) and TonB of S. marcescens (TonB SM ) (20, 36) . The TonB YE protein failed to interact with colicins (completely with D, Ia, and Ib and partially with B and M) and also with E. coli receptors (36) . The fact that the TonB protein of E. coli was not able to mediate the translocation of colicin F Y through the bacterial envelope of an E. coli yiuR ϩ strain could result from the inefficient energizing of the YiuR protein by TonB of E. coli (TonB EC ) and/or from inefficient interaction between colicin F Y and TonB EC . The lowest sequence identity was found in the middle part of the TonB proteins of E. coli and Y. kristensenii, which was previously described as an important region for interaction with TonB boxes of colicins or receptors (7, 20) . Although deletion of Q160 from the TonB protein resulted in colicin-specific decreased susceptibility (78) , deletion of seven amino acids (157S to Y163) from TonB caused complete resistance to all of the colicins tested (78) . The authors hypothesized that the Q160 region may be a part of a larger region that is required for contact with the outer membrane receptor. TonB EC and TonB YK differ at position 160 (Q and K, respectively) and only 3 out of 7 amino acids residues were identical in the 157-to-163 region.
The TonB box sequence of YiuR was identical in all four species Y. enterocolitica, Y. kristensenii, Y. pestis, and Y. pseudotuberculosis (DTMVVTA). A very similar TonB box was found in the N terminus of colicin F Y (DTMTVTG). In contrast, the TonB box sequences of the Cir protein and colicin Ia/Ib are ETMVVTA and EIMAVDI, respectively. Since it is known that TonB box substitutions leading to inactive mutants can be suppressed by mutations in TonB around position 160 (6), it is likely that TonB boxes evolved together with TonB proteins. In fact, evolution of colicin TonB boxes together with TonB could result in novel colicin types with different spectra of susceptible bacterial strains. The observed similarity between the Cir and YiuR proteins, together with the partial cross-immunity of colicin F Y and colicin Ib producers, suggests a common evolutionary origin of both the colicin F Y -YiuR and colicin Ib-Cir systems.
The above-described colicin F Y is a novel colicin type similar to previously described colicins with susceptible strains in the genus Yersinia and is especially active against strains of Y. enterocolitica.
The susceptible yersiniae are killed via YiuR-mediated reception, TonB-mediated translocation through the cell envelope, and the pore-forming lethal effect on the cell membrane.
